Zamann Pharma Support logo

Siedlerstraße 7 | 68623 Lampertheim, Germany

info@zamann-pharma.com

Request an appointment now

Innovations and highlights in the Pharma industry 

Dive deep into the world of Pharma with Zamann’s Expert Blog. Our industry-leading professionals share insights on global project management, quality consultancy, digitalization, and more. Stay updated with trends and innovations transforming the Pharma industry. 

News and more

Novogene Expands Single-Cell Sequencing; Can Validation Control the Data Chain?

Novogene Europe has expanded its single-cell RNA sequencing capability at the Cambridge Omics Centre in the UK. The new service brings advanced 10x Genomics Chromium workflows closer to academic, biotech and biopharma researchers. While the expansion can accelerate biomarker research
  • News
Novogene Expands Single-Cell Sequencing; Can Validation Control the Data Chain?

BeOne Adds $300M in US Manufacturing; GMP Readiness Could Decide Its 2029 Launch

BeOne Medicines is investing another $300 million in its Princeton West Innovation Campus in Hopewell, New Jersey, taking its total investment in the site beyond $1 billion. The expansion will add a three-storey, 145,000-square-foot building for small-molecule drug product manufacturing,
  • News
BeOne Adds $300M in US Manufacturing; GMP Readiness Could Decide Its 2029 Launch

6 Sigma Software in Pharma in 2026: Digital Tools for Quality Improvement

Explore how Six Sigma software supports DMAIC, process capability analysis, root cause investigations, and CAPA effectiveness across regulated pharmaceutical operations. The article explains the controls quality teams need to create reliable data, defensible decisions, and inspection-ready evidence.
  • Blog, Computerized System Validation
Pharmaceutical quality specialist reviewing control charts, process capability analysis, CAPA effectiveness, and DMAIC methodology on a digital dashboard in a modern manufacturing laboratory

FDA Panel Backs Four Peptides; Scientists Still Question Their Identity

An FDA advisory committee has narrowly supported adding BPC-157, KPV, TB-500, and MOTS-c-related substances to the list of bulk ingredients that may be used by eligible 503A compounding pharmacies. The decision could reshape access to peptides already promoted across wellness
  • News
FDA Panel Backs Four Peptides; Scientists Still Question Their Identity

FDA Weighs Tavneos Withdrawal; Amgen’s Reanalysis Fails to Confirm Week-52 Superiority

Amgen has submitted a new evidence package to defend Tavneos and request an FDA hearing. However, the dispute no longer focuses only on whether the drug can help patients with ANCA-associated vasculitis. The regulator now questions whether the pivotal ADVOCATE
  • News
FDA Weighs Tavneos Withdrawal; Amgen’s Reanalysis Fails to Confirm Week-52 Superiority

FDA Expanded AI; Leadership Turnover Leaves Pharma With New AI Questions

The FDA has expanded artificial intelligence across regulatory reviews, inspections, and administrative work. However, the departure of former commissioner Dr. Marty Makary and other senior technology leaders has created uncertainty around the agency’s AI strategy. Although the FDA continues to
  • News
FDA Expanded AI; Leadership Turnover Leaves Pharma With New AI Questions

Ashlins Calls Interferon Alpha-2b De-Risked; FDA Evidence Gap Remains

Ashlins Pharmaceuticals has licensed ex-China rights to develop products using Lee’s Pharm’s interferon alpha-2b API in a deal worth up to $31 million. The rare disease startup now plans to raise about $50 million and believes the funding could take
  • News
Ashlins Calls Interferon Alpha-2b De-Risked; FDA Evidence Gap Remains

History of Pharma Digitalization in 2026: Digital Transformation to Pharma 4.0

This article traces the evolution of pharmaceutical technology from controlled electronic records and process analytical technology to connected manufacturing, AI oversight, and Pharma 4.0, showing how digital systems reshaped GMP evidence, data integrity, and inspection readiness.
  • Blog, Computerized System Validation
Pharmaceutical manufacturing line showing process analytical technology, connected digital systems, real-time quality data, and Pharma 4.0 operations.